A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease
Clinical trial NCT00724048 · COMPLETED
Trial details
- NCT number
- NCT00724048
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-24
- Primary completion
- 2010-07-26
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.